Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
EJNMMI Radiopharmacy and Chemistry
|
October 16, 2024
First-in-human study of D6-[<sup>18</sup>F]FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [<sup>18</sup>F]FP-(+)-DTBZ (AV-133)
Ruiyue Zhao, Jinhua Chen, Ting Ye, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 29, 2024
Determining the optimal pharmacokinetic modelling and simplified quantification method of [<sup>18</sup>F]AlF-P16-093 for patients with primary prostate cancer (PPCa)
Ruiyue Zhao, Zeheng Xia, Miao Ke, et al.
Molecular Imaging and Biology
|
March 29, 2022
Preliminary Evaluation of <sup>68</sup>Ga-P16-093, a PET Radiotracer Targeting Prostate-Specific Membrane Antigen in Prostate Cancer
Hwan Lee, Joshua S Scheuermann, Anthony J Young, et al.
Molecular Imaging and Biology
|
August 21, 2019
[<sup>68</sup>Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [<sup>68</sup>Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence
Mark A Green, Gary D Hutchins, Clinton D Bahler, et al.
Urologic Oncology
|
November 4, 2022
Assessing extra-prostatic extension for surgical guidance in prostate cancer: Comparing two PSMA-PET tracers with the standard-of-care
Clinton D Bahler, Mark A Green, Mark A Tann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 24, 2024
Comparison of novel PSMA-targeting [<sup>177</sup>Lu]Lu-P17-087 with its albumin binding derivative [<sup>177</sup>Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study
Linlin Li, Jiarou Wang, Guochang Wang, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 6, 2018
Synthesis of l-[4-<sup>11</sup> C]Asparagine by Ring-Opening Nucleophilic <sup>11</sup> C-Cyanation Reaction of a Chiral Cyclic Sulfamidate Precursor
Youwen Xu, Aylin Sibel Cankaya, Ruma Hoque, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 17, 2024
First-in-human study of dosimetry, safety and efficacy for [<sup>177</sup>Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases
Ruiyue Zhao, Jie Lv, Mingzhao Li, et al.
Nuclear Medicine and Biology
|
June 27, 2007
Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug
Sung Won Kim, Yu-Shin Ding, David Alexoff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2007
PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine
Joanna S Fowler, Carsten Kroll, Richard Ferrieri, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
EJNMMI Radiopharmacy and Chemistry
|
October 16, 2024
First-in-human study of D6-[<sup>18</sup>F]FP-(+)-DTBZ, a novel VMAT2 tracer: whole-body biodistribution and brain PET comparison with [<sup>18</sup>F]FP-(+)-DTBZ (AV-133)
Ruiyue Zhao, Jinhua Chen, Ting Ye, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 29, 2024
Determining the optimal pharmacokinetic modelling and simplified quantification method of [<sup>18</sup>F]AlF-P16-093 for patients with primary prostate cancer (PPCa)
Ruiyue Zhao, Zeheng Xia, Miao Ke, et al.
Molecular Imaging and Biology
|
March 29, 2022
Preliminary Evaluation of <sup>68</sup>Ga-P16-093, a PET Radiotracer Targeting Prostate-Specific Membrane Antigen in Prostate Cancer
Hwan Lee, Joshua S Scheuermann, Anthony J Young, et al.
Molecular Imaging and Biology
|
August 21, 2019
[<sup>68</sup>Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [<sup>68</sup>Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence
Mark A Green, Gary D Hutchins, Clinton D Bahler, et al.
Urologic Oncology
|
November 4, 2022
Assessing extra-prostatic extension for surgical guidance in prostate cancer: Comparing two PSMA-PET tracers with the standard-of-care
Clinton D Bahler, Mark A Green, Mark A Tann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
April 24, 2024
Comparison of novel PSMA-targeting [<sup>177</sup>Lu]Lu-P17-087 with its albumin binding derivative [<sup>177</sup>Lu]Lu-P17-088 in metastatic castration-resistant prostate cancer patients: a first-in-human study
Linlin Li, Jiarou Wang, Guochang Wang, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
March 6, 2018
Synthesis of l-[4-<sup>11</sup> C]Asparagine by Ring-Opening Nucleophilic <sup>11</sup> C-Cyanation Reaction of a Chiral Cyclic Sulfamidate Precursor
Youwen Xu, Aylin Sibel Cankaya, Ruma Hoque, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 17, 2024
First-in-human study of dosimetry, safety and efficacy for [<sup>177</sup>Lu]Lu-P15-073: a novel bisphosphonate-based radioligand therapy (RLT) agent for bone metastases
Ruiyue Zhao, Jie Lv, Mingzhao Li, et al.
Nuclear Medicine and Biology
|
June 27, 2007
Synthesis and positron emission tomography studies of C-11-labeled isotopomers and metabolites of GTS-21, a partial alpha7 nicotinic cholinergic agonist drug
Sung Won Kim, Yu-Shin Ding, David Alexoff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2007
PET studies of d-methamphetamine pharmacokinetics in primates: comparison with l-methamphetamine and ( --)-cocaine
Joanna S Fowler, Carsten Kroll, Richard Ferrieri, et al.
Page
of 7